| 1988 |
The RAD9 gene product is essential for DNA damage-induced cell cycle arrest in G2 phase in S. cerevisiae; rad9 cells fail to arrest after irradiation and continue dividing until death, while repair can still occur if cells are artificially blocked in G2, indicating RAD9 controls the checkpoint rather than repair per se. |
Genetic analysis of rad9 mutants with X-ray irradiation, cell cycle analysis, microtubule poison arrest experiments |
Science |
High |
3291120
|
| 1993 |
RAD9 is required for G1 cell cycle arrest after UV, 4NQO, or gamma radiation in S. cerevisiae, defining a second RAD9-dependent checkpoint at the G1/S transition in addition to the previously described G2 checkpoint. |
Genetic analysis of rad9 mutants with synchronization by alpha-factor, cell cycle progression assays after UV/gamma irradiation |
Proceedings of the National Academy of Sciences |
High |
8367452
|
| 1995 |
Single-stranded DNA at telomeres (arising from Cdc13p failure) constitutes a specific signal activating the RAD9 checkpoint; cdc13 rad9 double mutants accumulate ssDNA at telomere-proximal sequences and divide at restrictive temperature, whereas cdc13 RAD9 cells arrest in G2. |
Genetic epistasis (cdc13 rad9 double mutants), DNA hybridization to detect ssDNA, analysis of mitotic recombination profile |
Molecular and Cellular Biology |
High |
7565765
|
| 1998 |
Rad9 is phosphorylated in response to DNA damage in S. cerevisiae, and phosphorylated Rad9 interacts specifically with the C-terminal FHA domain of Rad53; inactivation of the FHA domain abolishes damage-dependent Rad53 phosphorylation and G2/M arrest. |
Co-immunoprecipitation, phosphorylation assays, FHA domain mutagenesis, cell cycle analysis |
Science |
High |
9657725
|
| 1999 |
The BRCT domain of S. cerevisiae Rad9 mediates Rad9-Rad9 oligomerization (self-interaction), with the BRCT domain preferentially binding hyperphosphorylated Rad9; BRCT mutations abolish Rad9 hyperphosphorylation, Rad53 phosphorylation, and checkpoint function. |
Two-hybrid assay, in vitro and in vivo co-immunoprecipitation, point mutagenesis of BRCT motifs, UV survival and checkpoint assays |
Current Biology |
High |
10339432
|
| 2000 |
Human RAD9 interacts with anti-apoptotic proteins BCL-2 and BCL-xL (but not BAX or BAD) via yeast two-hybrid and co-immunoprecipitation; overexpression of RAD9 induces apoptosis blocked by BCL-2 or BCL-xL, and antisense RAD9 suppresses MMS-induced cell death. |
Yeast two-hybrid, co-immunoprecipitation, overexpression and antisense knockdown in mammalian cells, apoptosis assays |
Nature Cell Biology |
High |
10620799
|
| 2000 |
Human Rad9 (hRad9) is localized exclusively in the nucleus and becomes conversion to an extraction-resistant nuclear form after DNA damage; this damage-induced chromatin-associated form co-interacts with hHus1 and inducibly phosphorylated hRad1. |
Immunolocalization, biochemical fractionation, co-immunoprecipitation, response to multiple DNA-damaging agents |
Journal of Biological Chemistry |
High |
10852904
|
| 2000 |
Rad9, Rad1, and Hus1 form a heterotrimeric PCNA-like ring (9-1-1 complex) in fission yeast (S. pombe); structure-based predictions confirmed by biochemical co-immunoprecipitation demonstrating Hus1-B in complex with Rad9 and Rad1; Rad17 controls nuclear localization of Hus1 but is in a distinct complex. |
Co-immunoprecipitation, gel filtration fractionation, indirect immunofluorescence, yeast two-hybrid, computational fold prediction validated biochemically |
Molecular and Cellular Biology |
High |
10648611
|
| 2001 |
S. cerevisiae Rad9 forms two distinct large soluble complexes: a larger (≥850 kDa) hypophosphorylated complex in undamaged cells and a smaller (560 kDa) hyperphosphorylated complex with Rad53 after DNA damage. The 560 kDa complex catalyzes Rad53 autophosphorylation in trans, activating and releasing Rad53, requiring Rad53 kinase activity but not Mec1/Tel1 once the complex forms. |
Gel filtration, co-immunoprecipitation, in vitro kinase assays with purified complexes, genetic epistasis |
Molecular Cell |
High |
11511366
|
| 2001 |
ATM directly phosphorylates human Rad9 at Ser272 in response to ionizing radiation in vitro and in vivo; this modification is delayed in ATM-deficient cells, and expression of hRad9 S272A disrupts IR-induced G1/S checkpoint activation and increases cellular IR sensitivity. |
In vitro kinase assay with ATM, in vivo phosphorylation by mass spectrometry/immunoblot, site-directed mutagenesis, checkpoint and survival assays in ATM-deficient cells |
Journal of Biological Chemistry |
High |
11278446
|
| 2002 |
Human Rad17 recruits the Rad9 (9-1-1) complex onto chromatin after DNA damage; Rad17 binds chromatin prior to damage and is phosphorylated by ATR after damage; Rad17 phosphorylation is not required for Rad9 loading; the Rad1-Rad9-Hus1 complex recruited by Rad17 enables ATR to recognize its substrates. |
Chromatin fractionation, co-immunoprecipitation, siRNA knockdown, phosphorylation assays |
Genes & Development |
High |
11799063
|
| 2002 |
Multiple Mec1/Tel1 consensus [S/T]Q sites within S. cerevisiae Rad9 are phosphorylated in response to DNA damage; these phosphorylation sites are selectively required for Rad53 (but not Chk1) checkpoint branch activation; phosphorylated Rad9 peptides bind Rad53 FHA domains in vitro. |
Mass spectrometry mapping of phosphorylation sites, site-directed mutagenesis, in vitro FHA domain binding assays, checkpoint activation assays |
Molecular Cell |
High |
12049741
|
| 2002 |
The C-terminal region of human Rad9 contains a nuclear localization sequence (NLS) essential for nuclear import of the entire hRad9-hRad1-hHus1 complex; deletion of this NLS causes cytoplasmic accumulation of hRad1 and hHus1 and abrogates the G2 checkpoint. |
Deletion mutagenesis, subcellular fractionation, siRNA knockdown, fluorescence microscopy, checkpoint assays |
Journal of Biological Chemistry |
High |
11994305
|
| 2003 |
Protein kinase Cδ (PKCδ) associates with and phosphorylates human Rad9 in vitro and in cells after DNA damage; PKCδ activation is necessary for 9-1-1 complex formation and for Rad9-Bcl-2 binding; inhibition of PKCδ attenuates Rad9-mediated apoptosis. |
Co-immunoprecipitation, in vitro kinase assay, PKCδ inhibition, 9-1-1 complex formation assays |
EMBO Journal |
High |
12628935
|
| 2003 |
Phosphorylation of the Rad9 C-terminal tail is required for genotoxin-activated Chk1 activation; nine phosphorylation sites in the Rad9 tail (all in the C-terminal 119 aa) were identified; tail phosphorylation mutants abrogate HU- and UV-induced S-phase arrest and sensitize cells to UV and HU. |
Mass spectrometry-based phosphosite mapping, site-directed mutagenesis in Mrad9-/- ES cells, checkpoint assays, clonogenic survival |
Journal of Biological Chemistry |
High |
12709442
|
| 2003 |
Caspase-3 cleaves human Rad9 at conserved sites during apoptosis; cleavage releases an N-terminal BH3-domain-containing fragment that translocates from the nucleus to the cytosol, binds BCL-xL, and promotes apoptosis; a cleavage-resistant Rad9 mutant protects cells from DNA damage-induced apoptosis. |
In vitro caspase cleavage assay, site-directed mutagenesis, caspase-3-deficient cell lines, immunofluorescence localization, apoptosis assays |
Oncogene |
High |
14508514
|
| 2004 |
S. pombe Rad9 C-terminal T412/S423 phosphorylation by Rad3(ATR) (and Tel1(ATM) after damage) is required for association with the two-BRCT-domain region of Rad4(TOPBP1); this interaction activates the Chk1 damage checkpoint but not the Cds1 replication checkpoint. |
Co-immunoprecipitation of phosphorylation-site mutants, in vivo phosphorylation mapping, checkpoint activation assays |
Genes & Development |
High |
15155581
|
| 2004 |
The human 9-1-1 complex (Rad9-Rad1-Hus1) directly binds and stimulates FEN1 (flap endonuclease 1) on flap, nick, and gapped DNA substrates simulating repair intermediates; stimulation partially requires 9-1-1 entry to double-stranded DNA ends but does not substitute for PCNA in DNA polymerase β stimulation. |
In vitro binding assay, in vitro FEN1 activity assays on defined DNA substrates, competition experiments |
PNAS |
High |
15556996
|
| 2004 |
The N-terminus of S. cerevisiae Rad9 contains a Chk1 activation domain (CAD) specifically required for Chk1 phosphorylation/activation but not for Rad53 activation, demonstrating separable functional domains within Rad9 for the two checkpoint kinase branches. |
Deletion mutagenesis of Rad9 N-terminus, kinase activation assays for Chk1 and Rad53, genetic epistasis with cdc13-1 and yku70Δ |
Journal of Cell Science |
High |
14709724
|
| 2004 |
Mec1 controls Rad9 accumulation at double-strand breaks (DSBs) in S. cerevisiae; Mec1 phosphorylates Rad9 S/TQ motifs in vitro, and multiple S/TQ mutations abolish Rad9 association with DSBs; Rad9-Rad53 interaction after DSB induction requires Mec1 kinase activity but Rad53 deletion does not affect Rad9-DSB association. |
ChIP (chromatin immunoprecipitation) at defined DSB, in vitro kinase assay with Mec1, S/TQ multi-site mutagenesis, co-immunoprecipitation |
Molecular and Cellular Biology |
High |
15060150
|
| 2004 |
Human RAD9 activates transcription of p21 by binding to a p53-consensus DNA-binding sequence in the p21 promoter, as demonstrated by EMSA; overexpression of hRAD9 increases p21 RNA and protein and transactivates the p21 promoter in reporter assays. |
EMSA (electrophoretic mobility-shift assay), luciferase reporter assay, Northern blot, microarray |
PNAS |
High |
15184659
|
| 2005 |
Dot1-dependent methylation of histone H3 Lys79 is required for Rad9 recruitment to DSBs and chromatin in S. cerevisiae; the Rad9 Tudor domain binds methylated H3-K79 in vitro and mediates focal accumulation at damage sites in vivo; loss of Dot1 or Tudor-domain mutation of Rad9 blocks Rad53 phosphorylation. |
Histone methyltransferase deletion epistasis, ChIP at DSBs, in vitro Tudor domain binding assay, Rad53 phosphorylation assay, Tudor domain point mutagenesis |
Molecular and Cellular Biology |
High |
16166626
|
| 2005 |
Rad9 acts as a bona fide adaptor enabling direct phosphorylation of Rad53 by Mec1 in S. cerevisiae; biochemical reconstitution showed efficient Rad53 phosphorylation by Mec1 requires purified Rad9; this stimulatory activity depends on phospho/FHA-dependent Rad9-Rad53 interaction allowing Rad53 to be recognized as a Mec1 substrate. |
In vitro reconstitution with purified Mec1, Rad9, and Rad53; MS-based phosphosite mapping; phospho-FHA interaction assays |
Current Biology |
High |
16085488
|
| 2005 |
Rad9 interacts with RPA70 and RPA32 subunits via an acidic peptide in the C-terminal RAD9 tail; this Rad9-RPA interaction promotes chromatin loading of the 9-1-1 complex and ATR signaling to CHK1; RPA knockdown blocks 9-1-1 chromatin association and 9-1-1 complex formation. |
Co-immunoprecipitation, siRNA knockdown of RPA, chromatin fractionation, immunofluorescence co-localization |
Oncogene |
High |
15897895
|
| 2006 |
The human 9-1-1 complex stimulates DNA ligase I activity in a PCNA-independent manner; 9-1-1 improves DNA ligase I binding to nicked dsDNA; the 9-1-1/ligase I complex can be co-immunoprecipitated from human cells and this interaction is enhanced by UV irradiation. |
In vitro ligation assay on defined substrates, co-immunoprecipitation from human cells, DNA-binding assay |
Journal of Biological Chemistry |
High |
16731526
|
| 2006 |
The mammalian 9-1-1 (Rad9/Rad1/Hus1) complex localizes to telomeres in human and mouse cells, associates with catalytically competent telomerase, and acts as a positive regulator of telomerase DNA polymerase activity; Hus1-deficient cells show severe telomere shortening. |
ChIP at telomeres, telomere length measurement (Q-FISH, Southern), co-immunoprecipitation of telomerase, Hus1 knockout mouse cells |
Current Biology |
High |
16890531
|
| 2007 |
The Tudor domain of S. cerevisiae Rad9 is necessary for in vitro binding to H3-K79me and for Rad9 focal accumulation in vivo after DNA damage; Tudor domain function in checkpoint activation is restricted to G1 phase and its role in DNA repair is restricted to G2. |
In vitro histone binding assay with Tudor domain, in vivo focus formation by fluorescence microscopy, cell cycle-staged checkpoint assays, genetic epistasis with dot1Δ |
Yeast |
High |
17243194
|
| 2007 |
Human NEIL1 DNA glycosylase interacts with all three 9-1-1 subunits (hRad9, hRad1, hHus1) individually and as a complex; the 9-1-1 complex significantly stimulates hNEIL1 glycosylase activity; hNEIL1 foci co-localize with hRad9 foci in H2O2-treated cells. |
Co-immunoprecipitation, GST pulldown, in vitro glycosylase activity assay, immunofluorescence co-localization |
Nucleic Acids Research |
High |
17395641
|
| 2008 |
The basic cleft of RPA70 N-terminal OB-fold domain directly binds RAD9 via an acidic peptide in the RAD9 C-terminal tail (the checkpoint recruitment domain, CRD); mutation of the RAD9 CRD impairs localization to damage sites without disrupting 9-1-1 complex formation or TopBP1 binding; disruption impairs ATR→CHK1 signaling. |
In vitro binding assay, site-directed mutagenesis of RAD9 CRD, chromatin fractionation, ATR signaling assays, NMR-validated RPA70N binding surface |
Molecular and Cellular Biology |
High |
18936170
|
| 2008 |
Dot1 histone methyltransferase and Rad9 inhibit single-stranded DNA accumulation at DSBs and uncapped telomeres; Rad9 binding to methylated H3-K79 via its Tudor domain inhibits Rad50-dependent nuclease resection; loss of Rad9/Dot1 leads to faster ssDNA accumulation and faster Mec1 activation. |
Quantitative ssDNA measurement (QAOS), chromatin immunoprecipitation, genetic epistasis with nuclease mutants, CDK1 bypass assays |
EMBO Journal |
High |
18418382
|
| 2008 |
TLK1B phosphorylates human Rad9 at S328; TLK1B interacts with Rad9 and promotes 9-1-1 complex assembly at DSBs; Rad9 and Asf1 compete for TLK1B binding; TLK1B promotes nucleosome reassembly adjacent to DSBs in a manner requiring interaction with Rad9. |
In vitro kinase assay, co-immunoprecipitation, chromatin immunoprecipitation at HO-induced DSB, site-directed mutagenesis (S328A), complementation in Rad9-null cells |
DNA Repair |
High |
18940270
|
| 2009 |
Crystal structures of the human Rad9-Hus1-Rad1 (9-1-1) complex (at 3.2 Å and 2.5 Å) reveal a closed toroidal PCNA-like ring with notable structural differences among subunits in interdomain connecting loops; biochemical analysis identifies a single repair enzyme-binding site on 9-1-1 competitively blocked by p21; Rad9 C-terminal tail involvement in DNA binding is demonstrated. |
X-ray crystallography, biochemical binding competition assays, electrophoretic mobility-shift assay with DNA |
Molecular Cell / Journal of Molecular Biology / Journal of Biological Chemistry |
High |
19446481 19464297 19535328
|
| 2010 |
CK2 phosphorylates Rad9 at Ser341 and Ser387 in the C-terminal tail; pSer387 mediates interaction with TopBP1 BRCT domains; phosphorylation of both sites is required for efficient TopBP1 interaction in vitro and for ATR-dependent checkpoint function; Rad9 S341A/S387A mutant causes hypersensitivity to UV and MMS. |
In vitro kinase assay with CK2, phosphomimetic/phospho-deficient mutagenesis, co-immunoprecipitation of TopBP1, cell survival assays |
Genes to Cells |
High |
20545769
|
| 2010 |
Crystal structure of the N-terminal region of human TopBP1 reveals a triple-BRCT domain; the second BRCT domain specifically binds phosphorylated Ser387 of Rad9, and this phosphorylation is generated by CK2. |
X-ray crystallography of TopBP1 BRCT domains, phosphopeptide binding assays, CK2 kinase assay |
Nucleic Acids Research |
High |
20724438
|
| 2010 |
Rad17 mediates the interaction of 9-1-1 with TopBP1 in Xenopus egg extracts; ATP binding to Rad17 is required for 9-1-1-TopBP1 association; ATP hydrolysis by Rad17 is required for 9-1-1 loading onto DNA; Rad17-dependent TopBP1 accumulation on chromatin requires both Rad17 and 9-1-1. |
Xenopus egg extract biochemistry, chromatin fractionation, Rad17 ATP-binding and hydrolysis mutants, dominant-negative 9-1-1 mutant unable to bind TopBP1 |
Molecular Biology of the Cell |
High |
20110345
|
| 2010 |
S. pombe Rad9 is phosphorylated by DDK (Hsk1/Cdc7) in response to replication-induced DNA damage; DDK phosphorylation disrupts Rad9-RPA interaction; this requires prior Rad3(ATR) phosphorylation and 9-1-1 chromatin loading; DDK phosphorylation-deficient Rad9 mutants show abnormal DNA repair foci and decreased viability after replication stress. |
In vitro kinase assay, phosphosite mutagenesis, co-immunoprecipitation, DNA repair focus formation assay, cell viability assay |
Molecular Cell |
High |
21095590
|
| 2011 |
Dpb11 forms a ternary complex with Mec1 and Rad9 required for efficient Rad9 phosphorylation in vitro and checkpoint activation in vivo; CDK phosphorylation of Rad9 on two key residues generates a Dpb11 BRCT-binding site, restricting this checkpoint signaling mechanism to post-G1 phases when CDK is active. |
In vitro phosphorylation reconstitution with purified Mec1/Dpb11/Rad9, CDK site mutagenesis, co-immunoprecipitation, checkpoint activation assays |
EMBO Journal |
High |
21946560
|
| 2011 |
PRMT5 interacts with and methylates human Rad9 on arginine residues; arginine methylation of Rad9 is required for S/M and G2/M checkpoint activation and for CHK1 activation; a methylation-deficient Rad9 mutant shows impaired Chk1 phosphorylation. |
Co-immunoprecipitation, in vitro methylation assay, site-directed mutagenesis, checkpoint activation assays |
Nucleic Acids Research |
High |
21321020
|
| 2012 |
Slx4-Rtt107 scaffold complex counteracts checkpoint adaptor Rad9 by competing with Rad9 for binding to Dpb11 and phosphorylated histone H2A, thereby dampening Rad53 hyperactivation at replication-induced lesions; deletion of Slx4/Rtt107 leads to Rad9-dependent Rad53 hyperactivation. |
Genetic epistasis (hypomorphic Rad53/H2A mutations rescue slx4/rtt107 sensitivity), co-immunoprecipitation, phosphorylation assays, checkpoint kinase activity assays |
Nature |
High |
23160493
|
| 2013 |
RAD9A is expressed in male germ cells with peak in late pachytene/diplotene stages and is associated with the XY body; germ-cell-specific Rad9a deletion (Stra8-Cre) causes male infertility due to meiotic arrest in pachytene with increased unrepaired DSBs (γH2AX and DMC1 foci on autosomal chromosome axes). |
Conditional knockout mouse (Stra8-Cre), TUNEL assay, immunofluorescence for γH2AX/DMC1/TOPBP1, spermatocyte staging |
Journal of Cell Science |
High |
23788429
|
| 2015 |
Yeast Rad9 (53BP1 ortholog) reduces Mre11 binding to a DSB; deletion of RAD9 leads to reduced Mre11 occupancy, Rad52 recruitment, efficient DSB end-tethering via Sgs1-dependent mechanism, and restored DSB repair in absence of Sae2 or with nuclease-deficient MRX. |
ChIP at defined DSB, genetic epistasis (rad9Δ suppresses sae2Δ repair defects), DSB end-tethering assays, live-cell imaging |
PLoS Genetics |
High |
25569305
|
| 2018 |
Sae2 antagonizes Rad9 accumulation at DSBs by competing with other Tel1 substrates for Tel1-mediated phosphorylation, thereby reducing Rad9 binding to chromatin and to Rad53; this Sae2 function is independent of Mre11 nuclease activity. |
ChIP of Rad9 at DSBs, Tel1 phosphorylation competition assays, genetic epistasis with sae2Δ and mre11-nd mutants, co-immunoprecipitation |
PNAS |
High |
30510002
|
| 2020 |
Yeast Rad9 promotes stable strand annealing between the recombinogenic filament and the donor template during homologous recombination by limiting strand rejection by Sgs1 and Mph1 helicases, thereby promoting long-tract gene conversion, crossover recombination, and break-induced replication after checkpoint activation. |
Genetic analysis of recombination outcomes, helicase mutant epistasis, physical recombination intermediate assays |
Nature Communications |
High |
32576832
|
| 2008 |
Rad9 interacts with the mismatch repair protein MLH1 in both human and mouse cells; a single point mutation in Rad9 that disrupts this interaction significantly reduces MMR activity without affecting checkpoint functions, demonstrating a specific Rad9 role in MMR via MLH1 interaction. |
Co-immunoprecipitation, point mutagenesis of Rad9, MMR activity assays, checkpoint assays as controls |
Nucleic Acids Research |
High |
18842633
|
| 2007 |
The 9-1-1 complex interacts with and stimulates APE1 (apurinic/apyrimidinic endonuclease 1) in vitro and in vivo; 9-1-1 preferentially stimulates APE1 and DNA polymerase β in reconstituted long-patch BER, revealing a hierarchy of 9-1-1 interactions with BER proteins. |
In vitro AP-endonuclease activity assay, co-immunoprecipitation, reconstituted LP-BER assay |
Nucleic Acids Research |
High |
17426133
|
| 2009 |
Rad9 protein is highly mobile in undamaged cells but becomes immobilized at nuclear foci upon genotoxic stress; UV-induced Rad9 foci form predominantly in G1/S and IR-induced foci in S/G2; Rad9 focus formation requires processing of DNA lesions into ssDNA intermediates by NER (UV) or CtIP-mediated resection (IR). |
FRAP in living cells, immunofluorescence, siRNA knockdown of XPA/XPC and CtIP, cell cycle staging |
Cell Cycle |
High |
19411845
|
| 2004 |
Deletion of mouse Rad9 (Mrad9) causes embryonic lethality at midgestation and embryonic fibroblast inviability; Mrad9-/- ES cells show increased spontaneous chromosomal aberrations, HPRT mutations, extreme sensitivity to UV/gamma/HU, and inability to maintain gamma-ray-induced G2 delay. |
Targeted gene deletion in mouse ES cells, chromosome aberration analysis, clonogenic survival assays, G2 checkpoint assays, complementation with human HRAD9 |
Molecular and Cellular Biology |
High |
15282322
|
| 2006 |
Human Rad9 (hRad9) interacts with hHus1 and hRad1, forming the 9-1-1 complex; disruption of Rad1 causes destabilization of Rad9 and Hus1 and disintegration of the complex; Rad1 loss impairs ATR-dependent Chk1 but not ATM-dependent Chk2 activation. |
siRNA knockdown of Rad1, co-immunoprecipitation, checkpoint kinase activation assays, S-phase arrest assays |
Oncogene |
High |
15184880
|
| 2014 |
9-1-1/TopBP1 interaction (mediated by CK2-phosphorylated Rad9 Ser387) activates ATR-ATRIP; TopBP1 and Rad9 can independently localize to UV damage sites; once co-recruited, 9-1-1/TopBP1 interaction induces ATR activation, which in turn promotes further TopBP1 accumulation in a positive feedback loop. |
Immunofluorescence at UV-damage sites, Rad9 phospho-deficient mutants, ATR inhibitor experiments, TopBP1/ATR co-localization assays |
DNA Repair |
High |
25091155
|
| 2012 |
Human 9-1-1/FEN1/DNA ternary complex structure determined by single-particle EM at 18 Å reveals key differences from PCNA/FEN1/DNA in FEN1 orientation and interactions, consistent with 9-1-1 providing greater stability for DNA repair vs PCNA flexibility in replication. |
Cryo-EM single-particle reconstruction, molecular dynamics simulations, comparison with PCNA structure |
PNAS |
High |
22586102
|